Nutrition in paediatric human immunodeficiency virus infection

T L Miller1

  • 1University of Rochester Medical Center, Children's Hospital at Strong, 601 Elmwood Avenue, Box 667, Rochester, NY 14642, USA. tracie_miller@urmc.rochester.edu

Insights

Children with human immunodeficiency virus (HIV) infection experience growth problems due to various factors. New nutritional issues like lipodystrophy are emerging with advanced HIV treatments.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Nutrition Science

Background:

  • Nutritional status is a significant challenge for children with human immunodeficiency virus (HIV) infection globally.
  • HIV-infected children exhibit impaired growth in height and weight compared to uninfected peers, a pattern that persists over time.
  • Factors such as infections, increased viral load, poor diet, malabsorption, and psychosocial issues contribute to growth deficits.

Purpose of the Study:

  • To review the nutritional challenges faced by children with HIV.
  • To discuss the impact of evolving antiretroviral therapies on the nutritional status of HIV-infected children.
  • To highlight emerging nutritional complications associated with HIV treatment.

Main Methods:

  • Literature review and synthesis of existing research on HIV and child nutrition.
  • Analysis of growth patterns in HIV-infected versus HIV-exposed, uninfected children.
  • Examination of the relationship between HIV disease progression, treatment regimens, and nutritional outcomes.

Main Results:

  • HIV-infected children demonstrate consistently poorer growth parameters (height and weight) than controls.
  • Acute infections and higher HIV viral load are associated with decreased growth.
  • Antiretroviral therapies, while extending lifespan, have introduced new nutritional problems like lipodystrophy, insulin resistance, and obesity.

Conclusions:

  • Growth faltering is a persistent issue in pediatric HIV, influenced by multifactorial causes.
  • Modern antiretroviral treatments have shifted nutritional concerns towards metabolic complications, including fat redistribution and potential cardiovascular risks.
  • Comprehensive nutritional management is crucial for improving long-term health outcomes in children living with HIV.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...